Effects of methylprednisolone administration on lymphocyte LECAM-1, CD44, and LFA-1 expression. Implications for steroid-induced lymphopenia.
Effects of methylprednisolone administration on lymphocyte LECAM-1, CD44, and LFA-1 expression. Implications for steroid-induced lymphopenia.
复制标题
甲基泼尼松龙给药对淋巴细胞 LECAM-1、CD44 和 LFA-1 表达的影响。
DOI:
10.1111/j.1749-6632.1993.tb17183.x
复制
发表时间:
1993
影响因子:
5.2
通讯作者:
Sackstein,R
中科院分区:
文献类型:
--
作者:
Sackstein,R
Corticosteroid therapy causes immunosuppression in part by depleting the bloodstream of the mature, recirculating pool of lymphocytes. This transient lymphopenia results from an inhibition of lymphocyte trafficking to peripheral lymph nodes, leading to a redistribution of circulating cells to other tissue compartments, such as bone The first step in the migration (“homing”) of lymphocytes to lymph node involves the specific attachment of the cells to lymph node high endothelial venules (HEV). 4 LECAM-1 (L-selectin), a 90,000 mw lymphocyte glycoprotein which mediates attachment to HEV, is the “lymph node homing receptor.” In addition to this protein, two accessory HEV-binding molecules have also been identified: LFA-1 (CDlla/CD18) and CD44. Despite extensive knowledge of the biochemistry of these proteins and numerous physiologic studies of lymphocyte migration following corticosteroid therapy, our knowledge into the underlying molecular mechanisms for the steroid-induced decrease in lymphocyte migration to lymph nodes is incomplete. In rodents, there is evidence that steroids may decrease the capacity of HEV to bind lymphocytes. 5, h In humans, this effect has not been demonstrated, and it may be hypothesized that steroids decrease expression of lymphocyte adhesion molecules specific for promoting entry into lymph node. The present study was undertaken to address this issue by analyzing the in vivo and in vitro effects of methylprednisolone on lymphocyte LECAh4-1, CD44, and LFA-1 expression.Flow cytometric analysis of peripheral blood lymphocytes isolated by density centrifugation was performed in tissue culture studies and following pulse methylprednisolone infusion in vivo. Six healthy volunteers underwent infusions of saline (placebo) and methylprednisolone (Solumedrol, 3 mg/kg in saline) over 15 minutes, and peripheral blood lymphocytes were isolated before, immediately after, and at 1, 2, 4, 8, 24, and 48 hours following infusions. Saline infusion (placebo) had no effect on lymphocyte counts or on the levels of expression of lymphocyte LECAM-1, CD44, or LFA-1 (both CDlla and CD18 chains). Following steroid infusion, lymphopenia